Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Platelet Apoptosis in Adult Immune Thrombocytopenia. Relationship with Auto-Antibodies, Platelet Function and Treatment

Geraldine Contrufo, Ana C Glembotsky, Nora P Goette, Paola R Lev, Matías Grodzielski, Marta S Pierdominici, Dardo Alberto Riveros, MD, Verónica S Montero, Alejandro García, Felisa C. Molinas, MD PhD, Paula G. Heller, MD, Rosana F Marta

Blood (2014) 124 (21): 2792.

https://doi.org/10.1182/blood.V124.21.2792.2792

Published: 2014

Journal Articles

Screening for MPL mutations in Essential Thrombocythemia and Primary Myelofibrosis: Normal Mpl Expression and Absence of Constitutive STAT3 and STAT5 Activation in MPL W515L-Positive Platelets.

Laura Korin, M.D., Ana C Glembotsky, Paola R Lev, Ph.D., Carlos D Chazarreta, Rosana F Marta, Ph.D., Felisa C. Molinas, MD, PhD, Paula Graciela Heller, M.D., Ph.D

Blood (2009) 114 (22): 3910.

https://doi.org/10.1182/blood.V114.22.3910.3910

Published: 2009

Journal Articles

Anti-Apoptotic Effect of Soluble IL-6 Receptor on Megakaryocytic Lineage in Physiologic Conditions and Essential Thrombocythemia.

Carlos D. Chazarreta, Nora P. Goette, Juan P. Salim, Paola R. Lev, PhD, Laura I. Kornblihtt, MD, PhD, Felisa C. Molinas, MD, PhD, Rosana F. Marta, PhD

Blood (2007) 110 (11): 4087.

https://doi.org/10.1182/blood.V110.11.4087.4087

Published: 2007

Journal Articles

Follow-Up of Clinical Manifestations and Platelet Function Test in Patients with Essential Thrombocythemia on Anagrelide Treatment.

Patricia S. Vassallu, MD, Nora P. Goette, Ana C. Glembotsky, Paula G. Heller, MD, Laura I. Kornblihtt, Ph.D, Paola R. Lev, Ph.D, Daniel C. Chazarreta, Juan P. Salim, Maria S. Laguna, Rosana F. Marta, Ph.D, Felisa C. Molinas, Ph.D.

Blood (2005) 106 (11): 4970.

https://doi.org/10.1182/blood.V106.11.4970.4970

Published: 2005

Journal Articles

Frequency of the JAK2V617F Mutation in Platelets from Essential Thrombocythemia (ET) Patients.

Paula G. Heller, MD, Paola R. Lev, PhD, Juan P. Salim, Laura I. Kornblihtt, M.D, PhD, Patricia S. Vassallu, MD, Nora P. Goette, Daniel C. Chazarreta, Ana C. Glembotsky, Rosana F. Marta, PhD, Felisa C. Molinas, M.D, PhD

Blood (2005) 106 (11): 4972.

https://doi.org/10.1182/blood.V106.11.4972.4972

Published: 2005

NARROW

Platelet Apoptosis in Adult Immune Thrombocytopenia. Relationship with Auto-Antibodies, Platelet Function and Treatment

Screening for MPL mutations in Essential Thrombocythemia and Primary Myelofibrosis: Normal Mpl Expression and Absence of Constitutive STAT3 and STAT5 Activation in MPL W515L-Positive Platelets.

Anti-Apoptotic Effect of Soluble IL-6 Receptor on Megakaryocytic Lineage in Physiologic Conditions and Essential Thrombocythemia.

Follow-Up of Clinical Manifestations and Platelet Function Test in Patients with Essential Thrombocythemia on Anagrelide Treatment.

Frequency of the JAK2V617F Mutation in Platelets from Essential Thrombocythemia (ET) Patients.

Email alerts

ASH Publications

American Society of Hematology

Platelet Apoptosis in Adult Immune Thrombocytopenia. Relationship with Auto-Antibodies, Platelet Function and Treatment

Screening for MPL mutations in Essential Thrombocythemia and Primary Myelofibrosis: Normal Mpl Expression and Absence of Constitutive STAT3 and STAT5 Activation in MPL W515L-Positive Platelets.

Anti-Apoptotic Effect of Soluble IL-6 Receptor on Megakaryocytic Lineage in Physiologic Conditions and Essential Thrombocythemia.

Follow-Up of Clinical Manifestations and Platelet Function Test in Patients with Essential Thrombocythemia on Anagrelide Treatment.

Frequency of the JAK2V617F Mutation in Platelets from Essential Thrombocythemia (ET) Patients.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only